nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—ABCG2—lung cancer	0.174	0.54	CbGaD
Pitavastatin—ALB—lung cancer	0.0758	0.235	CbGaD
Pitavastatin—ABCB1—lung cancer	0.0723	0.225	CbGaD
Pitavastatin—ORM1—Gefitinib—lung cancer	0.0339	0.0669	CbGbCtD
Pitavastatin—SLCO2B1—Erlotinib—lung cancer	0.0297	0.0588	CbGbCtD
Pitavastatin—SLCO1B3—Paclitaxel—lung cancer	0.0242	0.0478	CbGbCtD
Pitavastatin—ABCG2—Topotecan—lung cancer	0.0226	0.0447	CbGbCtD
Pitavastatin—ABCG2—Gefitinib—lung cancer	0.0207	0.0408	CbGbCtD
Pitavastatin—ABCG2—Teniposide—lung cancer	0.02	0.0396	CbGbCtD
Pitavastatin—ORM1—Erlotinib—lung cancer	0.02	0.0396	CbGbCtD
Pitavastatin—SLCO1B3—Docetaxel—lung cancer	0.0175	0.0345	CbGbCtD
Pitavastatin—ALB—Gefitinib—lung cancer	0.0142	0.0282	CbGbCtD
Pitavastatin—SLCO1B1—Irinotecan—lung cancer	0.0139	0.0275	CbGbCtD
Pitavastatin—SLCO1B3—Methotrexate—lung cancer	0.0126	0.0249	CbGbCtD
Pitavastatin—ABCC2—Paclitaxel—lung cancer	0.0124	0.0245	CbGbCtD
Pitavastatin—ABCG2—Erlotinib—lung cancer	0.0122	0.0242	CbGbCtD
Pitavastatin—ABCC2—Irinotecan—lung cancer	0.0122	0.0241	CbGbCtD
Pitavastatin—ABCG2—Paclitaxel—lung cancer	0.0112	0.0221	CbGbCtD
Pitavastatin—ABCG2—Irinotecan—lung cancer	0.011	0.0218	CbGbCtD
Pitavastatin—ABCC2—Vinblastine—lung cancer	0.0108	0.0214	CbGbCtD
Pitavastatin—ABCC2—Cisplatin—lung cancer	0.00995	0.0197	CbGbCtD
Pitavastatin—ABCC2—Etoposide—lung cancer	0.00977	0.0193	CbGbCtD
Pitavastatin—ABCG2—Cisplatin—lung cancer	0.00899	0.0178	CbGbCtD
Pitavastatin—ABCC2—Docetaxel—lung cancer	0.00894	0.0177	CbGbCtD
Pitavastatin—ABCG2—Etoposide—lung cancer	0.00884	0.0175	CbGbCtD
Pitavastatin—ALB—Erlotinib—lung cancer	0.00842	0.0166	CbGbCtD
Pitavastatin—ABCB1—Topotecan—lung cancer	0.00815	0.0161	CbGbCtD
Pitavastatin—ABCG2—Docetaxel—lung cancer	0.00809	0.016	CbGbCtD
Pitavastatin—CYP2C9—Gefitinib—lung cancer	0.00768	0.0152	CbGbCtD
Pitavastatin—ALB—Irinotecan—lung cancer	0.0076	0.015	CbGbCtD
Pitavastatin—ABCB1—Gefitinib—lung cancer	0.00745	0.0147	CbGbCtD
Pitavastatin—CYP2C9—Teniposide—lung cancer	0.00744	0.0147	CbGbCtD
Pitavastatin—SLCO1B1—Methotrexate—lung cancer	0.00735	0.0145	CbGbCtD
Pitavastatin—ABCC2—Doxorubicin—lung cancer	0.00667	0.0132	CbGbCtD
Pitavastatin—CYP2C8—Erlotinib—lung cancer	0.00651	0.0129	CbGbCtD
Pitavastatin—ABCC2—Methotrexate—lung cancer	0.00646	0.0128	CbGbCtD
Pitavastatin—ABCG2—Doxorubicin—lung cancer	0.00603	0.0119	CbGbCtD
Pitavastatin—CYP2C8—Paclitaxel—lung cancer	0.00596	0.0118	CbGbCtD
Pitavastatin—ABCG2—Methotrexate—lung cancer	0.00584	0.0115	CbGbCtD
Pitavastatin—ABCB1—Vinorelbine—lung cancer	0.00574	0.0113	CbGbCtD
Pitavastatin—CYP2C8—Etoposide—lung cancer	0.00471	0.00931	CbGbCtD
Pitavastatin—ABCB1—Crizotinib—lung cancer	0.00457	0.00903	CbGbCtD
Pitavastatin—ABCB1—Gemcitabine—lung cancer	0.00446	0.00882	CbGbCtD
Pitavastatin—ABCB1—Erlotinib—lung cancer	0.00441	0.00871	CbGbCtD
Pitavastatin—CYP2C9—Paclitaxel—lung cancer	0.00415	0.00821	CbGbCtD
Pitavastatin—ABCB1—Paclitaxel—lung cancer	0.00403	0.00797	CbGbCtD
Pitavastatin—ALB—Methotrexate—lung cancer	0.00402	0.00796	CbGbCtD
Pitavastatin—ABCB1—Irinotecan—lung cancer	0.00398	0.00786	CbGbCtD
Pitavastatin—ABCB1—Vinblastine—lung cancer	0.00354	0.00699	CbGbCtD
Pitavastatin—CYP2C9—Cisplatin—lung cancer	0.00334	0.00661	CbGbCtD
Pitavastatin—ABCB1—Cisplatin—lung cancer	0.00324	0.00641	CbGbCtD
Pitavastatin—ABCB1—Etoposide—lung cancer	0.00319	0.0063	CbGbCtD
Pitavastatin—ABCB1—Docetaxel—lung cancer	0.00292	0.00576	CbGbCtD
Pitavastatin—ABCB1—Doxorubicin—lung cancer	0.00217	0.0043	CbGbCtD
Pitavastatin—ABCB1—Methotrexate—lung cancer	0.00211	0.00416	CbGbCtD
Pitavastatin—Atorvastatin—AHR—lung cancer	0.00098	0.26	CrCbGaD
Pitavastatin—Fluvastatin—UGT1A1—lung cancer	0.000793	0.21	CrCbGaD
Pitavastatin—Atorvastatin—UGT1A1—lung cancer	0.00069	0.183	CrCbGaD
Pitavastatin—SLCO1B1—mammary gland—lung cancer	0.000623	0.0837	CbGeAlD
Pitavastatin—SLCO2B1—mammary gland—lung cancer	0.000551	0.074	CbGeAlD
Pitavastatin—Rosuvastatin—ABCG2—lung cancer	0.000551	0.146	CrCbGaD
Pitavastatin—ALB—mammary gland—lung cancer	0.000504	0.0677	CbGeAlD
Pitavastatin—HMGCR—respiratory system—lung cancer	0.000434	0.0582	CbGeAlD
Pitavastatin—SLCO1B3—lung—lung cancer	0.000381	0.0512	CbGeAlD
Pitavastatin—SLCO2B1—respiratory system—lung cancer	0.000367	0.0493	CbGeAlD
Pitavastatin—HMGCR—epithelium—lung cancer	0.000362	0.0487	CbGeAlD
Pitavastatin—HMGCR—bronchus—lung cancer	0.000357	0.0479	CbGeAlD
Pitavastatin—CYP2C8—mammary gland—lung cancer	0.000354	0.0476	CbGeAlD
Pitavastatin—Fluvastatin—CYP1A1—lung cancer	0.000349	0.0927	CrCbGaD
Pitavastatin—HMGCR—trachea—lung cancer	0.00032	0.043	CbGeAlD
Pitavastatin—CYP2C9—mammary gland—lung cancer	0.000315	0.0423	CbGeAlD
Pitavastatin—HMGCR—cardiac atrium—lung cancer	0.000301	0.0404	CbGeAlD
Pitavastatin—HMGCR—bone marrow—lung cancer	0.000254	0.0341	CbGeAlD
Pitavastatin—Rosuvastatin—ALB—lung cancer	0.00024	0.0638	CrCbGaD
Pitavastatin—HMGCR—lung—lung cancer	0.00023	0.0309	CbGeAlD
Pitavastatin—ORM1—bone marrow—lung cancer	0.000225	0.0302	CbGeAlD
Pitavastatin—Nasopharyngitis—Docetaxel—lung cancer	0.000206	0.00276	CcSEcCtD
Pitavastatin—Discomfort—Vinorelbine—lung cancer	0.000204	0.00274	CcSEcCtD
Pitavastatin—Constipation—Vinblastine—lung cancer	0.000204	0.00273	CcSEcCtD
Pitavastatin—Dyspepsia—Topotecan—lung cancer	0.000204	0.00273	CcSEcCtD
Pitavastatin—ORM1—lung—lung cancer	0.000204	0.0273	CbGeAlD
Pitavastatin—Dyspepsia—Erlotinib—lung cancer	0.000202	0.00271	CcSEcCtD
Pitavastatin—Fatigue—Topotecan—lung cancer	0.0002	0.00268	CcSEcCtD
Pitavastatin—Constipation—Topotecan—lung cancer	0.000198	0.00266	CcSEcCtD
Pitavastatin—Fatigue—Erlotinib—lung cancer	0.000198	0.00265	CcSEcCtD
Pitavastatin—Rash—Teniposide—lung cancer	0.000197	0.00264	CcSEcCtD
Pitavastatin—Dermatitis—Teniposide—lung cancer	0.000197	0.00264	CcSEcCtD
Pitavastatin—Feeling abnormal—Vinblastine—lung cancer	0.000197	0.00263	CcSEcCtD
Pitavastatin—Constipation—Erlotinib—lung cancer	0.000196	0.00263	CcSEcCtD
Pitavastatin—Headache—Teniposide—lung cancer	0.000196	0.00263	CcSEcCtD
Pitavastatin—SLCO2B1—lung—lung cancer	0.000195	0.0262	CbGeAlD
Pitavastatin—Gastrointestinal pain—Vinblastine—lung cancer	0.000195	0.00261	CcSEcCtD
Pitavastatin—Back pain—Irinotecan—lung cancer	0.000194	0.0026	CcSEcCtD
Pitavastatin—Muscle spasms—Irinotecan—lung cancer	0.000193	0.00258	CcSEcCtD
Pitavastatin—Feeling abnormal—Topotecan—lung cancer	0.000191	0.00256	CcSEcCtD
Pitavastatin—Hypoaesthesia—Etoposide—lung cancer	0.00019	0.00255	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Topotecan—lung cancer	0.000189	0.00254	CcSEcCtD
Pitavastatin—Back pain—Gemcitabine—lung cancer	0.000189	0.00253	CcSEcCtD
Pitavastatin—Abdominal pain—Vinblastine—lung cancer	0.000189	0.00253	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Erlotinib—lung cancer	0.000187	0.00251	CcSEcCtD
Pitavastatin—Hypoaesthesia—Paclitaxel—lung cancer	0.000187	0.0025	CcSEcCtD
Pitavastatin—Ill-defined disorder—Irinotecan—lung cancer	0.000186	0.00249	CcSEcCtD
Pitavastatin—Nausea—Teniposide—lung cancer	0.000186	0.00249	CcSEcCtD
Pitavastatin—Hepatic failure—Methotrexate—lung cancer	0.000184	0.00247	CcSEcCtD
Pitavastatin—Urticaria—Topotecan—lung cancer	0.000184	0.00247	CcSEcCtD
Pitavastatin—Abdominal pain—Topotecan—lung cancer	0.000183	0.00246	CcSEcCtD
Pitavastatin—Abdominal pain—Erlotinib—lung cancer	0.000181	0.00243	CcSEcCtD
Pitavastatin—Ill-defined disorder—Gemcitabine—lung cancer	0.000181	0.00243	CcSEcCtD
Pitavastatin—Malaise—Irinotecan—lung cancer	0.000181	0.00242	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000181	0.00242	CcSEcCtD
Pitavastatin—Renal failure acute—Methotrexate—lung cancer	0.000179	0.00241	CcSEcCtD
Pitavastatin—Malaise—Gemcitabine—lung cancer	0.000176	0.00236	CcSEcCtD
Pitavastatin—Hypersensitivity—Vinblastine—lung cancer	0.000176	0.00236	CcSEcCtD
Pitavastatin—Muscle spasms—Cisplatin—lung cancer	0.000175	0.00234	CcSEcCtD
Pitavastatin—Jaundice—Docetaxel—lung cancer	0.000173	0.00232	CcSEcCtD
Pitavastatin—Asthenia—Vinblastine—lung cancer	0.000171	0.00229	CcSEcCtD
Pitavastatin—Fatigue—Vinorelbine—lung cancer	0.000171	0.00229	CcSEcCtD
Pitavastatin—Hypersensitivity—Topotecan—lung cancer	0.000171	0.00229	CcSEcCtD
Pitavastatin—Constipation—Vinorelbine—lung cancer	0.000169	0.00227	CcSEcCtD
Pitavastatin—Ill-defined disorder—Cisplatin—lung cancer	0.000169	0.00226	CcSEcCtD
Pitavastatin—Discomfort—Irinotecan—lung cancer	0.000168	0.00226	CcSEcCtD
Pitavastatin—Asthenia—Topotecan—lung cancer	0.000166	0.00223	CcSEcCtD
Pitavastatin—Myalgia—Gemcitabine—lung cancer	0.000166	0.00223	CcSEcCtD
Pitavastatin—Arthralgia—Gemcitabine—lung cancer	0.000166	0.00223	CcSEcCtD
Pitavastatin—Confusional state—Irinotecan—lung cancer	0.000165	0.00221	CcSEcCtD
Pitavastatin—Asthenia—Erlotinib—lung cancer	0.000164	0.00221	CcSEcCtD
Pitavastatin—Discomfort—Gemcitabine—lung cancer	0.000164	0.0022	CcSEcCtD
Pitavastatin—Malaise—Cisplatin—lung cancer	0.000164	0.0022	CcSEcCtD
Pitavastatin—Pruritus—Topotecan—lung cancer	0.000164	0.0022	CcSEcCtD
Pitavastatin—Feeling abnormal—Vinorelbine—lung cancer	0.000163	0.00219	CcSEcCtD
Pitavastatin—Diarrhoea—Vinblastine—lung cancer	0.000163	0.00219	CcSEcCtD
Pitavastatin—Pruritus—Erlotinib—lung cancer	0.000162	0.00217	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Vinorelbine—lung cancer	0.000162	0.00217	CcSEcCtD
Pitavastatin—Atorvastatin—ABCB1—lung cancer	0.000162	0.0429	CrCbGaD
Pitavastatin—Back pain—Etoposide—lung cancer	0.000161	0.00216	CcSEcCtD
Pitavastatin—Muscle spasms—Etoposide—lung cancer	0.00016	0.00215	CcSEcCtD
Pitavastatin—Hepatic failure—Doxorubicin—lung cancer	0.00016	0.00214	CcSEcCtD
Pitavastatin—Hepatitis—Docetaxel—lung cancer	0.000159	0.00213	CcSEcCtD
Pitavastatin—Diarrhoea—Topotecan—lung cancer	0.000159	0.00213	CcSEcCtD
Pitavastatin—Hypoaesthesia—Docetaxel—lung cancer	0.000158	0.00212	CcSEcCtD
Pitavastatin—Back pain—Paclitaxel—lung cancer	0.000158	0.00212	CcSEcCtD
Pitavastatin—Dizziness—Vinblastine—lung cancer	0.000158	0.00211	CcSEcCtD
Pitavastatin—HMGCR—lymph node—lung cancer	0.000157	0.0211	CbGeAlD
Pitavastatin—Urticaria—Vinorelbine—lung cancer	0.000157	0.00211	CcSEcCtD
Pitavastatin—Muscle spasms—Paclitaxel—lung cancer	0.000157	0.00211	CcSEcCtD
Pitavastatin—Diarrhoea—Erlotinib—lung cancer	0.000157	0.0021	CcSEcCtD
Pitavastatin—Abdominal pain—Vinorelbine—lung cancer	0.000157	0.0021	CcSEcCtD
Pitavastatin—Renal failure acute—Doxorubicin—lung cancer	0.000155	0.00208	CcSEcCtD
Pitavastatin—Myalgia—Cisplatin—lung cancer	0.000155	0.00208	CcSEcCtD
Pitavastatin—Ill-defined disorder—Etoposide—lung cancer	0.000155	0.00207	CcSEcCtD
Pitavastatin—Dizziness—Topotecan—lung cancer	0.000153	0.00205	CcSEcCtD
Pitavastatin—Discomfort—Cisplatin—lung cancer	0.000153	0.00205	CcSEcCtD
Pitavastatin—Dizziness—Erlotinib—lung cancer	0.000152	0.00203	CcSEcCtD
Pitavastatin—Ill-defined disorder—Paclitaxel—lung cancer	0.000152	0.00203	CcSEcCtD
Pitavastatin—Malaise—Etoposide—lung cancer	0.00015	0.00201	CcSEcCtD
Pitavastatin—Headache—Vinblastine—lung cancer	0.000149	0.002	CcSEcCtD
Pitavastatin—Insomnia—Irinotecan—lung cancer	0.000148	0.00198	CcSEcCtD
Pitavastatin—Malaise—Paclitaxel—lung cancer	0.000147	0.00197	CcSEcCtD
Pitavastatin—Rash—Topotecan—lung cancer	0.000146	0.00196	CcSEcCtD
Pitavastatin—Hypersensitivity—Vinorelbine—lung cancer	0.000146	0.00196	CcSEcCtD
Pitavastatin—Dermatitis—Topotecan—lung cancer	0.000146	0.00196	CcSEcCtD
Pitavastatin—Headache—Topotecan—lung cancer	0.000145	0.00195	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000145	0.00194	CcSEcCtD
Pitavastatin—Rash—Erlotinib—lung cancer	0.000145	0.00194	CcSEcCtD
Pitavastatin—Dermatitis—Erlotinib—lung cancer	0.000144	0.00194	CcSEcCtD
Pitavastatin—Insomnia—Gemcitabine—lung cancer	0.000144	0.00193	CcSEcCtD
Pitavastatin—Dyspepsia—Irinotecan—lung cancer	0.000144	0.00193	CcSEcCtD
Pitavastatin—Headache—Erlotinib—lung cancer	0.000144	0.00193	CcSEcCtD
Pitavastatin—Pain in extremity—Doxorubicin—lung cancer	0.000143	0.00192	CcSEcCtD
Pitavastatin—Asthenia—Vinorelbine—lung cancer	0.000142	0.00191	CcSEcCtD
Pitavastatin—Nausea—Vinblastine—lung cancer	0.000142	0.0019	CcSEcCtD
Pitavastatin—Fatigue—Irinotecan—lung cancer	0.000141	0.00189	CcSEcCtD
Pitavastatin—Pruritus—Vinorelbine—lung cancer	0.00014	0.00188	CcSEcCtD
Pitavastatin—Discomfort—Etoposide—lung cancer	0.00014	0.00188	CcSEcCtD
Pitavastatin—Constipation—Irinotecan—lung cancer	0.00014	0.00187	CcSEcCtD
Pitavastatin—ORM1—lymph node—lung cancer	0.000139	0.0187	CbGeAlD
Pitavastatin—Myalgia—Paclitaxel—lung cancer	0.000139	0.00186	CcSEcCtD
Pitavastatin—Arthralgia—Paclitaxel—lung cancer	0.000139	0.00186	CcSEcCtD
Pitavastatin—Nausea—Topotecan—lung cancer	0.000138	0.00185	CcSEcCtD
Pitavastatin—Discomfort—Paclitaxel—lung cancer	0.000137	0.00184	CcSEcCtD
Pitavastatin—Abdominal discomfort—Methotrexate—lung cancer	0.000137	0.00184	CcSEcCtD
Pitavastatin—Fatigue—Gemcitabine—lung cancer	0.000137	0.00184	CcSEcCtD
Pitavastatin—Confusional state—Etoposide—lung cancer	0.000137	0.00184	CcSEcCtD
Pitavastatin—Constipation—Gemcitabine—lung cancer	0.000136	0.00183	CcSEcCtD
Pitavastatin—Nausea—Erlotinib—lung cancer	0.000136	0.00183	CcSEcCtD
Pitavastatin—Diarrhoea—Vinorelbine—lung cancer	0.000136	0.00182	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000135	0.00181	CcSEcCtD
Pitavastatin—Feeling abnormal—Irinotecan—lung cancer	0.000135	0.00181	CcSEcCtD
Pitavastatin—ABCG2—bone marrow—lung cancer	0.000135	0.0181	CbGeAlD
Pitavastatin—Confusional state—Paclitaxel—lung cancer	0.000134	0.0018	CcSEcCtD
Pitavastatin—Back pain—Docetaxel—lung cancer	0.000134	0.0018	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Irinotecan—lung cancer	0.000134	0.00179	CcSEcCtD
Pitavastatin—SLCO2B1—lymph node—lung cancer	0.000133	0.0179	CbGeAlD
Pitavastatin—Muscle spasms—Docetaxel—lung cancer	0.000133	0.00178	CcSEcCtD
Pitavastatin—Erectile dysfunction—Methotrexate—lung cancer	0.000132	0.00177	CcSEcCtD
Pitavastatin—Feeling abnormal—Gemcitabine—lung cancer	0.000131	0.00176	CcSEcCtD
Pitavastatin—Dizziness—Vinorelbine—lung cancer	0.000131	0.00176	CcSEcCtD
Pitavastatin—Abdominal pain—Irinotecan—lung cancer	0.000129	0.00173	CcSEcCtD
Pitavastatin—Nasopharyngitis—Doxorubicin—lung cancer	0.000128	0.00172	CcSEcCtD
Pitavastatin—Rash—Vinorelbine—lung cancer	0.000125	0.00168	CcSEcCtD
Pitavastatin—Dermatitis—Vinorelbine—lung cancer	0.000125	0.00167	CcSEcCtD
Pitavastatin—Headache—Vinorelbine—lung cancer	0.000124	0.00166	CcSEcCtD
Pitavastatin—Influenza—Doxorubicin—lung cancer	0.000124	0.00166	CcSEcCtD
Pitavastatin—Feeling abnormal—Cisplatin—lung cancer	0.000122	0.00164	CcSEcCtD
Pitavastatin—ALB—lymph node—lung cancer	0.000122	0.0164	CbGeAlD
Pitavastatin—ABCG2—lung—lung cancer	0.000122	0.0164	CbGeAlD
Pitavastatin—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000121	0.00163	CcSEcCtD
Pitavastatin—Insomnia—Paclitaxel—lung cancer	0.000121	0.00162	CcSEcCtD
Pitavastatin—Hypersensitivity—Irinotecan—lung cancer	0.00012	0.00161	CcSEcCtD
Pitavastatin—Arthralgia—Docetaxel—lung cancer	0.000118	0.00158	CcSEcCtD
Pitavastatin—Myalgia—Docetaxel—lung cancer	0.000118	0.00158	CcSEcCtD
Pitavastatin—Nausea—Vinorelbine—lung cancer	0.000118	0.00158	CcSEcCtD
Pitavastatin—Dyspepsia—Paclitaxel—lung cancer	0.000117	0.00157	CcSEcCtD
Pitavastatin—Asthenia—Irinotecan—lung cancer	0.000117	0.00157	CcSEcCtD
Pitavastatin—Fatigue—Etoposide—lung cancer	0.000117	0.00157	CcSEcCtD
Pitavastatin—Constipation—Etoposide—lung cancer	0.000116	0.00156	CcSEcCtD
Pitavastatin—Fatigue—Paclitaxel—lung cancer	0.000115	0.00154	CcSEcCtD
Pitavastatin—Hepatitis—Methotrexate—lung cancer	0.000115	0.00154	CcSEcCtD
Pitavastatin—ABCC2—lymph node—lung cancer	0.000114	0.0154	CbGeAlD
Pitavastatin—Asthenia—Gemcitabine—lung cancer	0.000114	0.00153	CcSEcCtD
Pitavastatin—Constipation—Paclitaxel—lung cancer	0.000114	0.00153	CcSEcCtD
Pitavastatin—Confusional state—Docetaxel—lung cancer	0.000114	0.00153	CcSEcCtD
Pitavastatin—ABCB1—respiratory system—lung cancer	0.000113	0.0152	CbGeAlD
Pitavastatin—Pruritus—Gemcitabine—lung cancer	0.000113	0.00151	CcSEcCtD
Pitavastatin—Feeling abnormal—Etoposide—lung cancer	0.000112	0.0015	CcSEcCtD
Pitavastatin—Diarrhoea—Irinotecan—lung cancer	0.000112	0.0015	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Etoposide—lung cancer	0.000111	0.00149	CcSEcCtD
Pitavastatin—Feeling abnormal—Paclitaxel—lung cancer	0.00011	0.00147	CcSEcCtD
Pitavastatin—Hypersensitivity—Cisplatin—lung cancer	0.000109	0.00147	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Paclitaxel—lung cancer	0.000109	0.00146	CcSEcCtD
Pitavastatin—Diarrhoea—Gemcitabine—lung cancer	0.000109	0.00146	CcSEcCtD
Pitavastatin—Dizziness—Irinotecan—lung cancer	0.000108	0.00145	CcSEcCtD
Pitavastatin—Urticaria—Etoposide—lung cancer	0.000108	0.00145	CcSEcCtD
Pitavastatin—Jaundice—Doxorubicin—lung cancer	0.000108	0.00145	CcSEcCtD
Pitavastatin—Abdominal pain—Etoposide—lung cancer	0.000107	0.00144	CcSEcCtD
Pitavastatin—Asthenia—Cisplatin—lung cancer	0.000106	0.00143	CcSEcCtD
Pitavastatin—Urticaria—Paclitaxel—lung cancer	0.000106	0.00142	CcSEcCtD
Pitavastatin—Abdominal pain—Paclitaxel—lung cancer	0.000105	0.00141	CcSEcCtD
Pitavastatin—Rash—Irinotecan—lung cancer	0.000103	0.00138	CcSEcCtD
Pitavastatin—Dermatitis—Irinotecan—lung cancer	0.000103	0.00138	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000103	0.00138	CcSEcCtD
Pitavastatin—Headache—Irinotecan—lung cancer	0.000102	0.00137	CcSEcCtD
Pitavastatin—Insomnia—Docetaxel—lung cancer	0.000102	0.00137	CcSEcCtD
Pitavastatin—Diarrhoea—Cisplatin—lung cancer	0.000102	0.00136	CcSEcCtD
Pitavastatin—Rash—Gemcitabine—lung cancer	0.0001	0.00135	CcSEcCtD
Pitavastatin—Dermatitis—Gemcitabine—lung cancer	0.0001	0.00134	CcSEcCtD
Pitavastatin—Hypersensitivity—Etoposide—lung cancer	0.0001	0.00134	CcSEcCtD
Pitavastatin—Headache—Gemcitabine—lung cancer	9.97e-05	0.00134	CcSEcCtD
Pitavastatin—Dyspepsia—Docetaxel—lung cancer	9.95e-05	0.00133	CcSEcCtD
Pitavastatin—Hepatitis—Doxorubicin—lung cancer	9.93e-05	0.00133	CcSEcCtD
Pitavastatin—Hypoaesthesia—Doxorubicin—lung cancer	9.88e-05	0.00132	CcSEcCtD
Pitavastatin—Hypersensitivity—Paclitaxel—lung cancer	9.82e-05	0.00132	CcSEcCtD
Pitavastatin—Asthenia—Etoposide—lung cancer	9.75e-05	0.00131	CcSEcCtD
Pitavastatin—Fatigue—Docetaxel—lung cancer	9.74e-05	0.00131	CcSEcCtD
Pitavastatin—Nausea—Irinotecan—lung cancer	9.71e-05	0.0013	CcSEcCtD
Pitavastatin—Constipation—Docetaxel—lung cancer	9.66e-05	0.0013	CcSEcCtD
Pitavastatin—Back pain—Methotrexate—lung cancer	9.65e-05	0.00129	CcSEcCtD
Pitavastatin—Pruritus—Etoposide—lung cancer	9.62e-05	0.00129	CcSEcCtD
Pitavastatin—Asthenia—Paclitaxel—lung cancer	9.56e-05	0.00128	CcSEcCtD
Pitavastatin—ABCB1—epithelium—lung cancer	9.46e-05	0.0127	CbGeAlD
Pitavastatin—Nausea—Gemcitabine—lung cancer	9.46e-05	0.00127	CcSEcCtD
Pitavastatin—Pruritus—Paclitaxel—lung cancer	9.43e-05	0.00126	CcSEcCtD
Pitavastatin—Rash—Cisplatin—lung cancer	9.36e-05	0.00125	CcSEcCtD
Pitavastatin—Dermatitis—Cisplatin—lung cancer	9.35e-05	0.00125	CcSEcCtD
Pitavastatin—Feeling abnormal—Docetaxel—lung cancer	9.31e-05	0.00125	CcSEcCtD
Pitavastatin—Diarrhoea—Etoposide—lung cancer	9.3e-05	0.00125	CcSEcCtD
Pitavastatin—Ill-defined disorder—Methotrexate—lung cancer	9.26e-05	0.00124	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Docetaxel—lung cancer	9.24e-05	0.00124	CcSEcCtD
Pitavastatin—Diarrhoea—Paclitaxel—lung cancer	9.12e-05	0.00122	CcSEcCtD
Pitavastatin—Malaise—Methotrexate—lung cancer	9e-05	0.00121	CcSEcCtD
Pitavastatin—Dizziness—Etoposide—lung cancer	8.99e-05	0.00121	CcSEcCtD
Pitavastatin—Abdominal pain—Docetaxel—lung cancer	8.93e-05	0.0012	CcSEcCtD
Pitavastatin—Dizziness—Paclitaxel—lung cancer	8.82e-05	0.00118	CcSEcCtD
Pitavastatin—Nausea—Cisplatin—lung cancer	8.82e-05	0.00118	CcSEcCtD
Pitavastatin—Rash—Etoposide—lung cancer	8.57e-05	0.00115	CcSEcCtD
Pitavastatin—Dermatitis—Etoposide—lung cancer	8.56e-05	0.00115	CcSEcCtD
Pitavastatin—Headache—Etoposide—lung cancer	8.52e-05	0.00114	CcSEcCtD
Pitavastatin—Arthralgia—Methotrexate—lung cancer	8.5e-05	0.00114	CcSEcCtD
Pitavastatin—Myalgia—Methotrexate—lung cancer	8.5e-05	0.00114	CcSEcCtD
Pitavastatin—Rash—Paclitaxel—lung cancer	8.41e-05	0.00113	CcSEcCtD
Pitavastatin—Dermatitis—Paclitaxel—lung cancer	8.4e-05	0.00113	CcSEcCtD
Pitavastatin—Discomfort—Methotrexate—lung cancer	8.39e-05	0.00113	CcSEcCtD
Pitavastatin—ABCB1—trachea—lung cancer	8.37e-05	0.0112	CbGeAlD
Pitavastatin—Back pain—Doxorubicin—lung cancer	8.36e-05	0.00112	CcSEcCtD
Pitavastatin—Headache—Paclitaxel—lung cancer	8.35e-05	0.00112	CcSEcCtD
Pitavastatin—ABCG2—lymph node—lung cancer	8.34e-05	0.0112	CbGeAlD
Pitavastatin—Hypersensitivity—Docetaxel—lung cancer	8.32e-05	0.00112	CcSEcCtD
Pitavastatin—Muscle spasms—Doxorubicin—lung cancer	8.31e-05	0.00111	CcSEcCtD
Pitavastatin—Confusional state—Methotrexate—lung cancer	8.21e-05	0.0011	CcSEcCtD
Pitavastatin—Asthenia—Docetaxel—lung cancer	8.11e-05	0.00109	CcSEcCtD
Pitavastatin—Nausea—Etoposide—lung cancer	8.08e-05	0.00108	CcSEcCtD
Pitavastatin—Ill-defined disorder—Doxorubicin—lung cancer	8.02e-05	0.00107	CcSEcCtD
Pitavastatin—Pruritus—Docetaxel—lung cancer	7.99e-05	0.00107	CcSEcCtD
Pitavastatin—Nausea—Paclitaxel—lung cancer	7.92e-05	0.00106	CcSEcCtD
Pitavastatin—Malaise—Doxorubicin—lung cancer	7.79e-05	0.00104	CcSEcCtD
Pitavastatin—Diarrhoea—Docetaxel—lung cancer	7.73e-05	0.00104	CcSEcCtD
Pitavastatin—Dizziness—Docetaxel—lung cancer	7.47e-05	0.001	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Methotrexate—lung cancer	7.42e-05	0.000995	CcSEcCtD
Pitavastatin—Insomnia—Methotrexate—lung cancer	7.37e-05	0.000988	CcSEcCtD
Pitavastatin—Arthralgia—Doxorubicin—lung cancer	7.36e-05	0.000986	CcSEcCtD
Pitavastatin—Myalgia—Doxorubicin—lung cancer	7.36e-05	0.000986	CcSEcCtD
Pitavastatin—Discomfort—Doxorubicin—lung cancer	7.27e-05	0.000974	CcSEcCtD
Pitavastatin—Dyspepsia—Methotrexate—lung cancer	7.17e-05	0.000961	CcSEcCtD
Pitavastatin—Rash—Docetaxel—lung cancer	7.12e-05	0.000955	CcSEcCtD
Pitavastatin—Dermatitis—Docetaxel—lung cancer	7.12e-05	0.000954	CcSEcCtD
Pitavastatin—Confusional state—Doxorubicin—lung cancer	7.11e-05	0.000953	CcSEcCtD
Pitavastatin—Headache—Docetaxel—lung cancer	7.08e-05	0.000949	CcSEcCtD
Pitavastatin—Fatigue—Methotrexate—lung cancer	7.02e-05	0.000941	CcSEcCtD
Pitavastatin—Nausea—Docetaxel—lung cancer	6.71e-05	0.0009	CcSEcCtD
Pitavastatin—Feeling abnormal—Methotrexate—lung cancer	6.71e-05	0.0009	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Methotrexate—lung cancer	6.66e-05	0.000893	CcSEcCtD
Pitavastatin—ABCB1—bone marrow—lung cancer	6.64e-05	0.00891	CbGeAlD
Pitavastatin—Urticaria—Methotrexate—lung cancer	6.47e-05	0.000867	CcSEcCtD
Pitavastatin—Abdominal pain—Methotrexate—lung cancer	6.44e-05	0.000863	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Doxorubicin—lung cancer	6.42e-05	0.000861	CcSEcCtD
Pitavastatin—Insomnia—Doxorubicin—lung cancer	6.38e-05	0.000855	CcSEcCtD
Pitavastatin—Dyspepsia—Doxorubicin—lung cancer	6.21e-05	0.000832	CcSEcCtD
Pitavastatin—Fatigue—Doxorubicin—lung cancer	6.08e-05	0.000815	CcSEcCtD
Pitavastatin—Constipation—Doxorubicin—lung cancer	6.03e-05	0.000809	CcSEcCtD
Pitavastatin—ABCB1—lung—lung cancer	6.01e-05	0.00808	CbGeAlD
Pitavastatin—Hypersensitivity—Methotrexate—lung cancer	6e-05	0.000804	CcSEcCtD
Pitavastatin—Asthenia—Methotrexate—lung cancer	5.84e-05	0.000783	CcSEcCtD
Pitavastatin—Feeling abnormal—Doxorubicin—lung cancer	5.81e-05	0.000779	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Doxorubicin—lung cancer	5.77e-05	0.000773	CcSEcCtD
Pitavastatin—Pruritus—Methotrexate—lung cancer	5.76e-05	0.000773	CcSEcCtD
Pitavastatin—Urticaria—Doxorubicin—lung cancer	5.6e-05	0.000751	CcSEcCtD
Pitavastatin—Abdominal pain—Doxorubicin—lung cancer	5.57e-05	0.000747	CcSEcCtD
Pitavastatin—Diarrhoea—Methotrexate—lung cancer	5.57e-05	0.000747	CcSEcCtD
Pitavastatin—Dizziness—Methotrexate—lung cancer	5.39e-05	0.000722	CcSEcCtD
Pitavastatin—Hypersensitivity—Doxorubicin—lung cancer	5.2e-05	0.000697	CcSEcCtD
Pitavastatin—Rash—Methotrexate—lung cancer	5.13e-05	0.000688	CcSEcCtD
Pitavastatin—Dermatitis—Methotrexate—lung cancer	5.13e-05	0.000688	CcSEcCtD
Pitavastatin—Headache—Methotrexate—lung cancer	5.1e-05	0.000684	CcSEcCtD
Pitavastatin—Asthenia—Doxorubicin—lung cancer	5.06e-05	0.000678	CcSEcCtD
Pitavastatin—Pruritus—Doxorubicin—lung cancer	4.99e-05	0.000669	CcSEcCtD
Pitavastatin—Nausea—Methotrexate—lung cancer	4.84e-05	0.000649	CcSEcCtD
Pitavastatin—Diarrhoea—Doxorubicin—lung cancer	4.82e-05	0.000647	CcSEcCtD
Pitavastatin—Dizziness—Doxorubicin—lung cancer	4.66e-05	0.000625	CcSEcCtD
Pitavastatin—Rash—Doxorubicin—lung cancer	4.45e-05	0.000596	CcSEcCtD
Pitavastatin—Dermatitis—Doxorubicin—lung cancer	4.44e-05	0.000596	CcSEcCtD
Pitavastatin—Headache—Doxorubicin—lung cancer	4.42e-05	0.000592	CcSEcCtD
Pitavastatin—Nausea—Doxorubicin—lung cancer	4.19e-05	0.000562	CcSEcCtD
Pitavastatin—ABCB1—lymph node—lung cancer	4.11e-05	0.00552	CbGeAlD
Pitavastatin—ALB—Metabolism—NCOA3—lung cancer	5.49e-06	6.34e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ALB—lung cancer	5.43e-06	6.28e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	5.42e-06	6.27e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTA1—lung cancer	5.42e-06	6.27e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ABCB1—lung cancer	5.4e-06	6.24e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—UGT1A1—lung cancer	5.4e-06	6.24e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	5.39e-06	6.23e-05	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PTEN—lung cancer	5.39e-06	6.23e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—POMC—lung cancer	5.37e-06	6.21e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ADCY1—lung cancer	5.37e-06	6.21e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ABCG2—lung cancer	5.37e-06	6.21e-05	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	5.37e-06	6.21e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CYP1A1—lung cancer	5.37e-06	6.2e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ABCC3—lung cancer	5.36e-06	6.2e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ADCY1—lung cancer	5.34e-06	6.17e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ABCG2—lung cancer	5.34e-06	6.17e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ERCC2—lung cancer	5.32e-06	6.15e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—TYMS—lung cancer	5.3e-06	6.13e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	5.29e-06	6.11e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ENO2—lung cancer	5.27e-06	6.09e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—HPGDS—lung cancer	5.27e-06	6.09e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GSTM1—lung cancer	5.24e-06	6.06e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ENO2—lung cancer	5.24e-06	6.05e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—HPGDS—lung cancer	5.24e-06	6.05e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CREBBP—lung cancer	5.23e-06	6.05e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PPP2R1B—lung cancer	5.23e-06	6.05e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CD—lung cancer	5.21e-06	6.02e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PPP2R1B—lung cancer	5.2e-06	6.01e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GNG11—lung cancer	5.2e-06	6.01e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AKR1C1—lung cancer	5.19e-06	6e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.16e-06	5.97e-05	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—EP300—lung cancer	5.14e-06	5.94e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.13e-06	5.93e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	5.11e-06	5.91e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTT1—lung cancer	5.11e-06	5.9e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CB—lung cancer	5.09e-06	5.88e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTT1—lung cancer	5.08e-06	5.87e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP2A6—lung cancer	5.05e-06	5.84e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GCLC—lung cancer	5.05e-06	5.84e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PTGS2—lung cancer	5.04e-06	5.83e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—UGT1A1—lung cancer	5.04e-06	5.83e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.03e-06	5.81e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP2A6—lung cancer	5.02e-06	5.8e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GCLC—lung cancer	5.02e-06	5.8e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5e-06	5.78e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CYP1A1—lung cancer	4.97e-06	5.74e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CD—lung cancer	4.96e-06	5.74e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALDOA—lung cancer	4.95e-06	5.73e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ERCC2—lung cancer	4.93e-06	5.7e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	4.92e-06	5.69e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ALB—lung cancer	4.9e-06	5.66e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GNG11—lung cancer	4.86e-06	5.62e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	4.84e-06	5.59e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NCOA3—lung cancer	4.81e-06	5.56e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CB—lung cancer	4.79e-06	5.54e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ENO1—lung cancer	4.79e-06	5.53e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.77e-06	5.51e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ENO1—lung cancer	4.76e-06	5.5e-05	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	4.75e-06	5.5e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PTGS2—lung cancer	4.75e-06	5.49e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.74e-06	5.48e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.71e-06	5.44e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ADCY1—lung cancer	4.68e-06	5.41e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ABCG2—lung cancer	4.68e-06	5.41e-05	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PIK3CA—lung cancer	4.67e-06	5.39e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—RAF1—lung cancer	4.65e-06	5.37e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALDOA—lung cancer	4.63e-06	5.35e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—APOA1—lung cancer	4.6e-06	5.32e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ENO2—lung cancer	4.59e-06	5.3e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—HPGDS—lung cancer	4.59e-06	5.3e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PPP2R1B—lung cancer	4.56e-06	5.27e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CB—lung cancer	4.54e-06	5.25e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NCOA3—lung cancer	4.49e-06	5.19e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTT1—lung cancer	4.45e-06	5.14e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.41e-06	5.1e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.41e-06	5.1e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GCLC—lung cancer	4.4e-06	5.08e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP2A6—lung cancer	4.4e-06	5.08e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PTEN—lung cancer	4.4e-06	5.08e-05	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	4.39e-06	5.07e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ABCG2—lung cancer	4.37e-06	5.05e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ADCY1—lung cancer	4.37e-06	5.05e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CB—lung cancer	4.33e-06	5e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	4.32e-06	4.99e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP2E1—lung cancer	4.29e-06	4.96e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PTGS2—lung cancer	4.29e-06	4.95e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ENO2—lung cancer	4.29e-06	4.95e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—HPGDS—lung cancer	4.29e-06	4.95e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP2E1—lung cancer	4.27e-06	4.93e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—APOA1—lung cancer	4.26e-06	4.93e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PPP2R1B—lung cancer	4.26e-06	4.92e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—NQO1—lung cancer	4.24e-06	4.91e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NQO1—lung cancer	4.22e-06	4.88e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CG—lung cancer	4.2e-06	4.86e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.2e-06	4.86e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—EP300—lung cancer	4.19e-06	4.85e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ENO1—lung cancer	4.17e-06	4.82e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IL2—lung cancer	4.17e-06	4.82e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	4.17e-06	4.82e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTT1—lung cancer	4.16e-06	4.8e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.16e-06	4.8e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PTEN—lung cancer	4.14e-06	4.79e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.13e-06	4.78e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.12e-06	4.76e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP2A6—lung cancer	4.11e-06	4.75e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GCLC—lung cancer	4.11e-06	4.75e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.09e-06	4.73e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.09e-06	4.73e-05	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	4.02e-06	4.65e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—POMC—lung cancer	4e-06	4.63e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—EP300—lung cancer	3.95e-06	4.57e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	3.9e-06	4.51e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CREBBP—lung cancer	3.9e-06	4.51e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ENO1—lung cancer	3.9e-06	4.5e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CG—lung cancer	3.89e-06	4.5e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.88e-06	4.49e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.83e-06	4.43e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—STK11—lung cancer	3.83e-06	4.42e-05	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—AKT1—lung cancer	3.81e-06	4.41e-05	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PIK3CA—lung cancer	3.8e-06	4.4e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—STK11—lung cancer	3.8e-06	4.4e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—EP300—lung cancer	3.74e-06	4.32e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP2E1—lung cancer	3.74e-06	4.32e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PTEN—lung cancer	3.74e-06	4.32e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—POMC—lung cancer	3.71e-06	4.28e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NQO1—lung cancer	3.7e-06	4.27e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CD—lung cancer	3.7e-06	4.27e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ALB—lung cancer	3.65e-06	4.22e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SRC—lung cancer	3.64e-06	4.2e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CREBBP—lung cancer	3.61e-06	4.17e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.59e-06	4.15e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.57e-06	4.13e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—EP300—lung cancer	3.56e-06	4.12e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—VEGFA—lung cancer	3.54e-06	4.1e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTP1—lung cancer	3.54e-06	4.09e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	3.53e-06	4.08e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTP1—lung cancer	3.52e-06	4.07e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—NRAS—lung cancer	3.5e-06	4.04e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP2E1—lung cancer	3.49e-06	4.04e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NQO1—lung cancer	3.45e-06	3.99e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CAT—lung cancer	3.44e-06	3.98e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CAT—lung cancer	3.43e-06	3.96e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.43e-06	3.96e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CD—lung cancer	3.42e-06	3.96e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.41e-06	3.94e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.38e-06	3.91e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ALB—lung cancer	3.38e-06	3.9e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.35e-06	3.87e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—MAPK3—lung cancer	3.35e-06	3.87e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ABCB1—lung cancer	3.35e-06	3.87e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—STK11—lung cancer	3.33e-06	3.85e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ABCB1—lung cancer	3.33e-06	3.85e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—TYMS—lung cancer	3.29e-06	3.8e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—TYMS—lung cancer	3.27e-06	3.78e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTM1—lung cancer	3.25e-06	3.76e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTM1—lung cancer	3.23e-06	3.74e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CB—lung cancer	3.22e-06	3.72e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTGS2—lung cancer	3.19e-06	3.69e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—STK11—lung cancer	3.11e-06	3.6e-05	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—AKT1—lung cancer	3.11e-06	3.59e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CA—lung cancer	3.1e-06	3.58e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTP1—lung cancer	3.08e-06	3.56e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP1A1—lung cancer	3.08e-06	3.56e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP1A1—lung cancer	3.07e-06	3.54e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ERCC2—lung cancer	3.06e-06	3.54e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ERCC2—lung cancer	3.04e-06	3.52e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—KRAS—lung cancer	3.01e-06	3.48e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CAT—lung cancer	3e-06	3.47e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CB—lung cancer	2.98e-06	3.45e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTGS2—lung cancer	2.96e-06	3.42e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.92e-06	3.38e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CA—lung cancer	2.92e-06	3.38e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTP1—lung cancer	2.88e-06	3.33e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—TYMS—lung cancer	2.87e-06	3.31e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTM1—lung cancer	2.83e-06	3.28e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CAT—lung cancer	2.8e-06	3.24e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.79e-06	3.22e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTEN—lung cancer	2.78e-06	3.22e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CA—lung cancer	2.77e-06	3.2e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ABCB1—lung cancer	2.73e-06	3.15e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP1A1—lung cancer	2.69e-06	3.11e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—TYMS—lung cancer	2.68e-06	3.1e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TP53—lung cancer	2.68e-06	3.09e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ERCC2—lung cancer	2.66e-06	3.08e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—EP300—lung cancer	2.65e-06	3.07e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTM1—lung cancer	2.65e-06	3.06e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—APOA1—lung cancer	2.65e-06	3.06e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CA—lung cancer	2.64e-06	3.05e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—APOA1—lung cancer	2.63e-06	3.04e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTEN—lung cancer	2.58e-06	2.98e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—HRAS—lung cancer	2.56e-06	2.96e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.53e-06	2.93e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—AKT1—lung cancer	2.53e-06	2.93e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.52e-06	2.91e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP1A1—lung cancer	2.51e-06	2.9e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ERCC2—lung cancer	2.49e-06	2.88e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—EP300—lung cancer	2.46e-06	2.84e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CG—lung cancer	2.42e-06	2.79e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CG—lung cancer	2.4e-06	2.78e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—AKT1—lung cancer	2.39e-06	2.76e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—APOA1—lung cancer	2.31e-06	2.66e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—POMC—lung cancer	2.3e-06	2.66e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—POMC—lung cancer	2.29e-06	2.64e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—AKT1—lung cancer	2.26e-06	2.61e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CREBBP—lung cancer	2.24e-06	2.59e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CREBBP—lung cancer	2.23e-06	2.57e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—AKT1—lung cancer	2.15e-06	2.49e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—APOA1—lung cancer	2.15e-06	2.49e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CD—lung cancer	2.12e-06	2.45e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CD—lung cancer	2.11e-06	2.44e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CG—lung cancer	2.1e-06	2.43e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ALB—lung cancer	2.1e-06	2.42e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.06e-06	2.38e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—POMC—lung cancer	2e-06	2.32e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CG—lung cancer	1.97e-06	2.27e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CA—lung cancer	1.96e-06	2.27e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CREBBP—lung cancer	1.95e-06	2.26e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—POMC—lung cancer	1.87e-06	2.16e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CB—lung cancer	1.85e-06	2.14e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CD—lung cancer	1.85e-06	2.14e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CB—lung cancer	1.84e-06	2.13e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTGS2—lung cancer	1.83e-06	2.12e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALB—lung cancer	1.83e-06	2.11e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTGS2—lung cancer	1.82e-06	2.11e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CREBBP—lung cancer	1.82e-06	2.11e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CA—lung cancer	1.82e-06	2.1e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CD—lung cancer	1.73e-06	2e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALB—lung cancer	1.71e-06	1.97e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CB—lung cancer	1.61e-06	1.86e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AKT1—lung cancer	1.6e-06	1.85e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTEN—lung cancer	1.6e-06	1.85e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTGS2—lung cancer	1.6e-06	1.85e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTEN—lung cancer	1.59e-06	1.84e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—EP300—lung cancer	1.53e-06	1.76e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—EP300—lung cancer	1.52e-06	1.75e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CB—lung cancer	1.51e-06	1.74e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTGS2—lung cancer	1.49e-06	1.73e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AKT1—lung cancer	1.49e-06	1.72e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTEN—lung cancer	1.39e-06	1.61e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—EP300—lung cancer	1.33e-06	1.54e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTEN—lung cancer	1.3e-06	1.5e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—EP300—lung cancer	1.24e-06	1.43e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CA—lung cancer	1.13e-06	1.3e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CA—lung cancer	1.12e-06	1.3e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CA—lung cancer	9.83e-07	1.14e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AKT1—lung cancer	9.22e-07	1.07e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CA—lung cancer	9.18e-07	1.06e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AKT1—lung cancer	9.17e-07	1.06e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AKT1—lung cancer	8.03e-07	9.28e-06	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AKT1—lung cancer	7.5e-07	8.67e-06	CbGpPWpGaD
